Eric Swierzynski, DPT | |
980 Professional Park Dr Ste D, Clarksville, TN 37040-5251 | |
(931) 221-9967 | |
Not Available |
Full Name | Eric Swierzynski |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 980 Professional Park Dr Ste D, Clarksville, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972083848 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 11692 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Eric Swierzynski, DPT 980 Professional Park Dr Ste D, Clarksville, TN 37040-5251 Ph: (931) 221-9967 | Eric Swierzynski, DPT 980 Professional Park Dr Ste D, Clarksville, TN 37040-5251 Ph: (931) 221-9967 |
News Archive
Longevity Biotech, Inc. has received an award from the National Multiple Sclerosis Society through Fast Forward, the Society's commercial research funding program, to evaluate LBT-3627 in preclinical models as a potential disease-modifying therapeutic agent.
In health research, most preliminary studies in animals only examine effects of drug treatment in one sex, assuming that males and females will have few differences in how a drug works.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that current and former users of marijuana are more likely to have prediabetes-the state of poor blood sugar control that can progress to type 2 diabetes-than never users of marijuana. However the researchers, led by Mike Bancks (University of Minnesota School of Public Health, Minneapolis, MN, USA) failed to establish a direct link between marijuana use and type 2 diabetes.
Antonio R. Gargiulo, MD of the Center for Infertility and Reproductive Surgery at Brigham and Women's Hospital completed a live surgery for the American Society of Reproductive Medicine, treating a patient suffering from uterine fibroids with a novel robotic surgical approach and a cutting edge laser technology developed at OmniGuide in Cambridge, MA.
Centocor, Inc., announced today that the U.S. Food and Drug Administration (FDA) has accepted its filing of a supplemental Biologics License Application (sBLA) for REMICADE® (infliximab) as first-line therapy, in combination with methotrexate, for the treatment of early rheumatoid arthritis (RA) patients with moderately-to-severely active disease. REMICADE®, in combination with methotrexate, is currently indicated in the U.S. for reducing signs and symptoms, inhibiting the progression of structural damage and improving physical function in patients with moderately-to-severely active RA who have had an inadequate response to methotrexate alone.
› Verified 9 days ago
Dr. Christopher J Siodlarz, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 141 Hillcrest Dr, Clarksville, TN 37043 Phone: 931-548-0967 Fax: 931-552-0999 | |
Angelica Elizabeth Lopez, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 250 Arrowood Dr, Clarksville, TN 37042 Phone: 931-245-4700 | |
Ms. Allison Kate Wiles, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 311 Landrum Pl Ste B400, Clarksville, TN 37043 Phone: 931-647-3553 | |
Dr. Dale P Cunningham, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 651 Dunlop Ln, Clarksville, TN 37040 Phone: 877-749-7428 Fax: 512-628-3314 | |
Katherine Allen, ATC Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 320 Drane St, Room 152, Clarksville, TN 37040 Phone: 931-221-7011 |